Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gerritsen

Showing results (131-140 of 224) with videos related to

Pageof 23
Sort By:
Human Gene Therapy|October 25, 2002
Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropismDaniëlle A M Heideman, Victor W van Beusechem, G Johan A Offerhaus, et al.
Neurosurgery|December 25, 2004
Oncolytic virotherapy of meningiomas in vitro with replication-competent adenovirusJacques Grill, Martine L M Lamfers, Victor W van Beusechem, et al.
Journal of Virology|February 28, 2002
Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolishedVictor W van Beusechem, Jacques Grill, D C Jeroen Mastenbroek, et al.
Molecular Cancer|January 25, 2008
Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastasesHarm C A Graat, Victor W van Beusechem, Frederik H E Schagen, et al.
BMJ Open|December 1, 2021
Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocolJeroen H A Creemers, Inka Pawlitzky, Konstantina Grosios, et al.
Targeted Oncology|April 13, 2018
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort StudyLotte M Knapen, Rutger H T Koornstra, Johanna H M Driessen, et al.
International Immunopharmacology|February 1, 2021
Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestaneAnnelieke E C A B Willemsen, Xuehui He, Bram van Cranenbroek, et al.
Oncoimmunology|May 4, 2016
Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cellsJoyce M van Dodewaard-de Jong, Saskia Jam Santegoets, Peter M van de Ven, et al.
Cancer Gene Therapy|July 31, 2001
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectorsD A Heideman, P J Snijders, M E Craanen, et al.
Radiation Oncology (London, England)|April 19, 2015
A cell-based high-throughput screening assay for radiation susceptibility using automated cell countingJasmina Hodzic, Ilse Dingjan, Mariëlle Jp Maas, et al.
Pageof 23

Showing results (131-140 of 224) with videos related to

Sort By:
Pageof 23
Human Gene Therapy|October 25, 2002
Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropismDaniëlle A M Heideman, Victor W van Beusechem, G Johan A Offerhaus, et al.
Neurosurgery|December 25, 2004
Oncolytic virotherapy of meningiomas in vitro with replication-competent adenovirusJacques Grill, Martine L M Lamfers, Victor W van Beusechem, et al.
Journal of Virology|February 28, 2002
Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolishedVictor W van Beusechem, Jacques Grill, D C Jeroen Mastenbroek, et al.
Molecular Cancer|January 25, 2008
Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastasesHarm C A Graat, Victor W van Beusechem, Frederik H E Schagen, et al.
BMJ Open|December 1, 2021
Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocolJeroen H A Creemers, Inka Pawlitzky, Konstantina Grosios, et al.
Targeted Oncology|April 13, 2018
The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort StudyLotte M Knapen, Rutger H T Koornstra, Johanna H M Driessen, et al.
International Immunopharmacology|February 1, 2021
Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestaneAnnelieke E C A B Willemsen, Xuehui He, Bram van Cranenbroek, et al.
Oncoimmunology|May 4, 2016
Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cellsJoyce M van Dodewaard-de Jong, Saskia Jam Santegoets, Peter M van de Ven, et al.
Cancer Gene Therapy|July 31, 2001
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectorsD A Heideman, P J Snijders, M E Craanen, et al.
Radiation Oncology (London, England)|April 19, 2015
A cell-based high-throughput screening assay for radiation susceptibility using automated cell countingJasmina Hodzic, Ilse Dingjan, Mariëlle Jp Maas, et al.
Pageof 23